Sleep quality following initiation of NIV in chronic hyperkapnic COPD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015496

Enrollment

Registered

2018-09-10

Start date

2018-11-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J44.9 J96.1

Interventions

Group 1: Sleep quality will be assed at baseline and following 3 months of noninvasive ventilation (NIV). In addition lung function and gas exchange as well as health related quality of life will be a

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Indication for home NIV in COPD following national guidelines

Exclusion criteria

Exclusion criteria: recent acute respiratory failure with hospital admission in the last 4 weeks, NIV-users

Design outcomes

Primary

Measure	Time frame
Rapid-Eye-Movement (REM)-sleep assessed by polysomnography at baseline and following 3 months of home NIV.	—

Secondary

Measure	Time frame
Accordingly to primary endpoint results of polysomnography, lung function, gas exchange and quality of life will be assessed at baseline and following 3 months of home NIV.	—

Countries

Germany

Contacts

Public ContactJan Hendrik Storre

Asklepios Fachkliniken München-Gauting Abteilung für Intensiv-, Schlaf- und Beatmungsmedizin

j.storre@asklepios.com+49 (89) 85791-4301

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026